What is the Aspire BioPharma, Inc. stock price forecast?

Aspire BioPharma, Inc. is currently trading at $0.02. View real-time AI analysis on Alpha Lenz.

What is Aspire BioPharma, Inc. insider trading activity?

View the latest insider trading data for Aspire BioPharma, Inc. on Alpha Lenz.

What is Aspire BioPharma, Inc.'s P/E ratio?

View Aspire BioPharma, Inc.'s valuation metrics on Alpha Lenz.

Aspire BioPharma, Inc.

NASDAQ · ASBPW

$0.02+0.00(+9.94%)Pre-market

Ask about Aspire BioPharma, Inc.'s future dividend policy...

Alpha Chat Insight

“Aspire BioPharma, Inc.'s ROE is 618.5%. Explore profitability and growth together.”

Ask for details →

Company Overview

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

CEOMr. Kraig T. Higginson

Websitehttps://aspirebiolabs.com

SectorHealthcare

IndustryBiotechnology

Company Statistics

FY 2025

Profile

N/AMarket Cap

$6.20KRevenue

0.00Shares Out

0Employees

Margins

-1.87%Gross

-249764.62%EBITDA

-312016.95%Operating

-394725.06%Pre-Tax

-394725.06%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-3353.18%ROA

618.48%ROE

-2184.64%ROIC

Financial Health

$1.00MCash & Cash Equivalents

$6.68MNet Debt

-120.58%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Aspire BioPharma, Inc.'s ROE is 618.5%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Aspire BioPharma, Inc. (ticker: ASBPW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology).

The current price is $0.02 with a P/E ratio of -x and P/B of -x.

ROE is 618.48% and operating margin is -312016.95%. Annual revenue is $6,202.